Schenone M, Dančík V, Wagner BK, Clemons PA. Target identification and mechanism of action in chemical biology and drug discovery. Nat Chem Biol. 2013;9(4):232-40. doi:10.1038/nchembio.1199.

Lennon NJ, Lintner RE, Anderson S, et al. A scalable, fully automated process for construction of sequence-ready barcoded libraries for 454. Genome Biol. 2010;11(2):R15. doi:10.1186/gb-2010-11-2-r15.

Stanley SA, Barczak AK, Silvis MR, et al. Identification of host-targeted small molecules that restrict intracellular Mycobacterium tuberculosis growth. PLoS Pathog. 2014;10(2):e1003946. doi:10.1371/journal.ppat.1003946.

Swamidass J, Bittker JA, Bodycombe NE, Ryder SP, Clemons PA. An economic framework to prioritize confirmatory tests after a high-throughput screen. J Biomol Screen. 2010;15(6):680-6. doi:10.1177/1087057110372803.

Wagner BK, Gilbert TJ, Hanai J- ichi, et al. A small-molecule screening strategy to identify suppressors of statin myopathy. ACS Chem Biol. 2011;6(9):900-4. doi:10.1021/cb200206w.

Martyn DC, Cortese JF, Tyndall E, et al. Antiplasmodial activity of piperazine sulfonamides. Bioorg Med Chem Lett. 2010;20(1):218-21. doi:10.1016/j.bmcl.2009.10.130.

Fischer K, Kettunen J, Würtz P, et al. Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons. PLoS Med. 2014;11(2):e1001606. doi:10.1371/journal.pmed.1001606.

Swamidass J, Calhoun BT, Bittker JA, Bodycombe NE, Clemons PA. Enhancing the rate of scaffold discovery with diversity-oriented prioritization. Bioinformatics. 2011;27(16):2271-8. doi:10.1093/bioinformatics/btr369.

Wagner BK. Screening: Low-fat worms on drugs. Nat Chem Biol. 2011;7(4):194-5. doi:10.1038/nchembio.540.

Walpita D, Hasaka T, Spoonamore J, et al. A human islet cell culture system for high-throughput screening. J Biomol Screen. 2012;17(4):509-18. doi:10.1177/1087057111430253.